Home › Funds › ARMISTICE CAPITAL, LLC › VSTM
ARMISTICE CAPITAL, LLC position in VSTM
VERASTEM INC · Health Care
ARMISTICE CAPITAL, LLC reported holding 7,024,000 shares of VSTM (VERASTEM INC) in its Q2 2026 13F filing — a position valued at US$26.8M, representing 0.35% of its reported portfolio and ranking #41 among its reported holdings. ARMISTICE CAPITAL, LLC has disclosed VSTM holdings in 6 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ARMISTICE CAPITAL, LLC's VSTM position evolved
ARMISTICE CAPITAL, LLC first disclosed a stake in VSTM in Q3 2024 at 1,364,000 shares (US$4.1M). The position peaked in Q4 2025 at 3,536,000 shares, worth US$27.3M. Across 6 filings, ARMISTICE CAPITAL, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 7,024,000 shares valued at US$26.8M — an increase of 2,432,000 shares quarter over quarter.. Notable position changes include a 69% increase in Q4 2025 (shares fell 31% over the following quarter), a 30% increase in Q1 2026 (shares fell 28% over the following quarter), a 53% increase in Q2 2026 (shares rose 111% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 1.36M | $4.08M | New |
| Q2 2025 | 2.14M | $8.86M | New |
| Q3 2025 | 2.10M | $18.51M | Reduce |
| Q4 2025 | 3.54M | $27.30M | Add |
| Q1 2026 | 4.59M | $24.34M | Add |
| Q2 2026 | 7.02M | $26.83M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VSTM and 13F data
VSTM (VERASTEM INC) is a Health Care company. 38 other funds we track also report a position in VSTM — the largest reported positions include Rosalind Advisors, Inc. (US$15.2M), Nantahala Capital Management, LLC (US$13.7M), Stonepine Capital Management, LLC (US$12.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VSTM
- Rosalind Advisors, Inc. 3.99M sh · $15.23M · Q2 2026
- Nantahala Capital Management, LLC 3.58M sh · $13.69M · Q2 2026
- Stonepine Capital Management, LLC 3.35M sh · $12.80M · Q2 2026
- Foresite Capital Management VI LLC 3.15M sh · $12.02M · Q2 2026
- AIGH Capital Management LLC 1.93M sh · $7.36M · Q2 2026
- Opaleye Management Inc. 1.80M sh · $6.88M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.47M sh · $5.61M · Q2 2026
- NEXTBio Capital Management LP 1.31M sh · $4.99M · Q2 2026
More on ARMISTICE CAPITAL, LLC
FAQ
How long has ARMISTICE CAPITAL, LLC held VSTM?
ARMISTICE CAPITAL, LLC has disclosed VSTM holdings in 6 of the last 8 reported quarters, going back to Q3 2024.
What is ARMISTICE CAPITAL, LLC's current position in VSTM?
As of Q2 2026, ARMISTICE CAPITAL, LLC holds 7.02M shares of VSTM (VERASTEM INC), valued at $26.83M, representing 0.35% of its reported portfolio and ranking #41.
Has ARMISTICE CAPITAL, LLC been buying or selling VSTM?
In the latest 13F filing (Q2 2026), ARMISTICE CAPITAL, LLC increased its position in VSTM. The position peaked in Q4 2025 at 3.54M shares.
Which other funds hold VSTM?
Other major institutional holders of VSTM include Rosalind Advisors, Inc., Nantahala Capital Management, LLC, Stonepine Capital Management, LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.